FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Fresenius Kabi 0.9% Sodium Chloride Injection Recall

0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single…

Fresenius Kabi USA, LLC · Lake Zurich, IL

Risk level
Class II
Reported by FDA
Apr 15, 2026
Recall ID
D-0431-2026
Check your lot numberHow we source this data

Summary

Fresenius Kabi recalled 0.9% Sodium Chloride Injection starting Mar 11, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0431-2026 on Apr 15, 2026. Reason: Lack of Assurance of Sterility. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility

Product description

0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05.

Lot numbers, UPCs & expiration codes

Batch# 6402290, 6402291, Exp Date: 01/31/2028; Batch# 6402411, Exp Date: 02/29/2028; Batch# 6402412, 6402419, 6402424, 6402425, 6402426, 6402427, Exp Date: 03/31/2028; Batch# 6402479, 6402480, 6402517, 6402571, Exp Date: 05/31/2028; Batch# 6402518, Exp Date: 06/30/2028.

Where it was sold

US Nationwide , Alaska, and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0431-2026
Classification
Class II
Status
Ongoing
Recall initiated
Mar 11, 2026
FDA report date
Apr 15, 2026
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA, LLC

Original FDA data

Every field from FDA enforcement report D-0431-2026, exactly as published.

Show all FDA fields
City
Lake Zurich
State
IL
Status
Ongoing
Country
United States
Event ID
98581
Address
3 Corporate Dr
Code information
Batch# 6402290, 6402291, Exp Date: 01/31/2028; Batch# 6402411, Exp Date: 02/29/2028; Batch# 6402412, 6402419, 6402424, 6402425, 6402426, 6402427, Exp Date: 03/31/2028; Batch# 6402479, 6402480, 6402517, 6402571, Exp Date: 05/31/2028; Batch# 6402518, Exp Date: 06/30/2028.
Postal code
60047-8930
Report date
Apr 15, 2026
Product type
Drugs
Recall number
D-0431-2026
Classification
Class II
Recalling firm
Fresenius Kabi USA, LLC
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05.
Distribution pattern
US Nationwide , Alaska, and Puerto Rico.
Recall initiation date
Mar 11, 2026
Initial firm notification
Letter
Center classification date
Apr 3, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0431-2026, published Apr 15, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls